By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Gliknik Inc. 

2330 W. Joppa Road
Suite 355
Lutherville  Maryland  21093  U.S.A.
Phone: n/a Fax: n/a



Company News
Pfizer Inc. (PFE) Grabs Autoimmune Diseases Drug Rights From Gliknik Inc. for $25 Million Upfront 9/30/2013 6:51:34 AM
Gliknik Inc. Adds Incyte Corporation (INCY) President & CEO Paul A. Friedman to its Board of Directors 2/25/2013 8:56:34 AM
Gliknik Inc. Announces Interim Clinical Data From Use of Its Immunomodulator Drug Candidate in Multiple Myeloma Patients 12/20/2012 9:56:53 AM
Gliknik Inc. Raises $4.9 Million in Series B Financing Led by Baxter Ventures 10/8/2012 10:41:44 AM
Published Preclinical Data Demonstrate Ability of Gliknik Inc.'s Recombinant Stradomers™ to Mimic Anti-Autoimmune Effect of IVIG 9/12/2012 12:07:29 PM
National Cancer Institute Awards Gliknik Inc. Up to $1.5 Million in SBIR Funding 10/3/2011 12:32:35 PM
Gliknik Inc. Announces Completion of $3.5 Million Equity Financing 1/5/2011 8:54:22 AM
2008 Mid-Atlantic Bio Exhibitor Profiles 10/21/2008 11:36:47 AM
University of Maryland, Baltimore BioPark Signs Gliknik Inc. First Tenant in Its BioInnovation Center in Building Two 1/10/2008 7:56:24 AM